Keck Graduate Institute

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Keck Graduate Institute
Keck Graduate Institute logo
Type Private
Established 1997
Endowment $36.9 million[1]
President Sheldon Schuster
Students 406 [2]
Location Claremont, CA, U.S.
Campus Suburban
Colors Teal and White         
Affiliations Claremont Colleges

The Keck Graduate Institute (KGI) is a private research graduate school in Claremont, California. Founded in 1997, it is the seventh and newest member of the Claremont Consortium. It offers seven academic programs in a range of disciplines with foci both in the life sciences industry and in applied life science research.

Academic programs at KGI are organized into two schools, the School of Applied Life Science (SALS) and the School of Pharmacy (SoP). In addition, KGI offers a selective four-year undergraduate program, the Minerva Schools at KGI, in partnership with the Minerva Project.


The decision to establish Keck Graduate Institute as a seventh Claremont College met with some opposition, particularly from faculty of the other Claremont Colleges who objected to its lack of tenure, and environmentalists who opposed its plans to build a campus next to the Bernard Field Station, an area of undeveloped scrubland. The environmental issue was largely settled when KGI decided to establish its campus at a different location, and other opposition gradually faded.[verification needed][3][4]


Keck Graduate Institute of Applied Life Sciences is accredited by the Accrediting Commission for Senior Colleges and Universities of the Western Association of Schools and Colleges. The School of Pharmacy has been granted Precandidate status by the Accreditation Council for Pharmacy Education (ACPE).

Research centers[edit]

KGI maintains four research centers:

  • The Center for Rare Disease Therapies
  • The Center for Biomarker Research
  • The Amgen Bioprocessing Center
  • The Center for Network Students

Spin-off companies[edit]

Ionian Technologies was founded in 2000, and was the first spin-off company to commercialize technology developed at KGI. Ionian focuses on molecular diagnostics for emerging and infectious diseases, and in 2004 was awarded a contract to develop a handheld biothreat detector using isothermal amplification of DNA. Other KGI startups include Zuyder Pharmaceuticals and Claremont BioSolutions.

See also[edit]


  1. ^ As of June 30, 2009. "U.S. and Canadian Institutions Listed by Fiscal Year 2009 Endowment Market Value and Percentage Change in Endowment Market Value from FY 2008 to FY 2009" (PDF). 2009 NACUBO-Commonfund Study of Endowments. National Association of College and University Business Officers. Retrieved February 17, 2010. 
  2. ^ "Keck Graduate Institute". Campus Discovery. Retrieved 1 April 2015. 
  3. ^ "Keck foes persist in fight". Los Angeles Times (Claremont supplement). November 23, 2000. 
  4. ^ Keck Graduate Institute To Celebrate 10th Year At Weekend Commencement Archived September 27, 2007, at the Wayback Machine.

External links[edit]

Coordinates: 34°05′34″N 117°43′23″W / 34.092796°N 117.723042°W / 34.092796; -117.723042